|
Wednesday, November 14, 2018
Print Current Session:
 |
|
|
Wednesday
SESSION 30:
NEW DEVELOPMENTS IN THE TREATMENT OF LOWER EXTREMITY INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI)
|
|
| SESSION 30 SCHEDULE | |
| 4:52 PM - 4:57 PM | How To Get Patients To Recognize That Exercise And Neuromuscular Stimulation (NMES) Are Good Treatments For IC And To Comply With Them |
|
Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| INTERMITTENT CLAUDICATION | |
| 4:58 PM - 5:03 PM | Update On Value And Logistics Of Exercise Treatment For Intermittent Claudication (IC): Things Are Getting Better And Why |
|
Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:04 PM - 5:09 PM | A Recently Completed RCT Of Endovascular Revascularization vs. Supervised Exercise For IC: The SUPER Trial Results: Outcomes, QOL And Cost Effectiveness; How Does It Compare With The Other IC RCTs |
|
Presenter(s):Mark J.W. Koelemay, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:10 PM - 5:15 PM | Exercise TcPO2 Can Distinguish Buttock IC From The Symptoms Of Spinal Stenosis: How Should Buttock IC Be Treated |
|
Presenter(s):Manju Kalra, MBBS Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:16 PM - 5:21 PM | New And Current Data On All Cause And Cardiovascular Mortality In Patients With IC And CLTI: Have Recent Improvement In Medical Treatment And Statins Made A Difference |
|
Presenter(s):Gert J. de Borst, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:22 PM - 5:27 PM | Differences In Decision Making For The Treatment Of IC In Europe And The US: Based On Data From The PORTRAIT Registry |
|
Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:28 PM - 5:33 PM | Panel Discussion |
| ACUTE LIMB ISCHEMIA (ALI) | |
| 5:33 PM - 5:38 PM | DEBATE: All ALI Patients Should Be Treated With An Endo First Policy And Over 90% Can Be Treated Entirely Endovascularly |
|
Presenter(s):Ali Amin, MD, RVT, FACS, FACC Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:39 PM - 5:44 PM | DEBATE: Not So: Some Patients With ALI Should Have An Open Procedure First And Over 10% Will Require Some Open Component: Which Ones |
|
Presenter(s):Joseph L. Mills, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:45 PM - 5:50 PM | More Effective Treatment Of ALI By Thrombolysis With Microbubbles And Ultrasound |
|
Presenter(s):Kak Khee Yeung, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:51 PM - 5:56 PM | Current And New Data On Morbidity And Mortality Risks After Lower Extremity Embolectomy/Thrombectomy For ALI Open And Endo: Is It Less Than In The Past And Why |
|
Presenter(s):Alik Farber, MD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 5:57 PM - 6:02 PM | Advances In The Endovascular Treatment Of ALI: Equipment, Techniques And Results |
|
Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
| View Slides in PDF | |
| 6:03 PM - 6:09 PM | Panel Discussion End of Program E |
| END OF SESSION 30 | |
| previous | next |